Your search for dabigatran returned 116 results

Your search for dabigatran returned 116 results

Sort Results:

Relevant Recent
News

Pradaxa Now Approved for Treating DVT/PE

The FDA has approved Pradaxa (dabigatran etexilate mesylate; Boehringer Ingelheim) for the treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE) in patients who have been treated with a parenteral anticoagulant for 5-10 days, and to reduce the risk of recurrent DVT and PE in previously treated patients.